Contract development and manufacturing organization (CDMO) Sterling Pharma Solutions said the expansion of its pilot plant facility is now operational at its UK site following a £6 million investment last year.   The new cGMP facility increases the existing pilot plant’s capacity by 33%, enhancing the CDMO’s scale-up capabilities and adding greater flexibility to cater for small to mid-scale clinical supply and commercial batch production.   The investment included the addition of three new reac...